These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6268770)

  • 61. The detection of Delta9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol (THCA) in whole blood using two-dimensional gas chromatography and EI-mass spectrometry.
    Scurlock RD; Ohlson GB; Worthen DK
    J Anal Toxicol; 2006 May; 30(4):262-6. PubMed ID: 16803665
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Difference in epoxides formation and their further metabolism between delta 9- and delta 8-tetrahydrocannabinols by human liver microsomes.
    Yamamoto I; Narimatsu S; Shimonishi T; Watanabe K; Yoshimura H
    J Pharmacobiodyn; 1984 Apr; 7(4):254-62. PubMed ID: 6088753
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Confirmation of cannabis use. II. Determination of tetrahydrocannabinol metabolites in urine and plasma by HPLC with ECD.
    Nakahara Y; Sekine H; Cook CE
    J Anal Toxicol; 1989; 13(1):22-4. PubMed ID: 2540383
    [TBL] [Abstract][Full Text] [Related]  

  • 64. delta 9-Tetrahydrocannabinol decreases turnover of brain histamine.
    Oishi R; Itoh Y; Nishibori M; Saeki K
    J Pharmacol Exp Ther; 1985 Feb; 232(2):513-8. PubMed ID: 2578567
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part I: development and validation of a pulmonary cannabinoid route of exposure for experimental pharmacology studies in rodents.
    Manwell LA; Charchoglyan A; Brewer D; Matthews BA; Heipel H; Mallet PE
    J Pharmacol Toxicol Methods; 2014; 70(1):120-7. PubMed ID: 24973534
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Quantification of Delta9-tetrahydrocannabinol and its major metabolites in meconium by gas chromatographic-mass spectrometric assay: assay validation and preliminary results of the "meconium project".
    Marchei E; Pellegrini M; Pacifici R; Palmi I; Lozano J; García-Algar O; Pichini S
    Ther Drug Monit; 2006 Oct; 28(5):700-6. PubMed ID: 17038890
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sensitive determination of THC and main metabolites in human plasma by means of microextraction in packed sorbent and gas chromatography-tandem mass spectrometry.
    Rosado T; Fernandes L; Barroso M; Gallardo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1043():63-73. PubMed ID: 27617793
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
    Manno JE; Manno BR; Kemp PM; Alford DD; Abukhalaf IK; McWilliams ME; Hagaman FN; Fitzgerald MJ
    J Anal Toxicol; 2001 Oct; 25(7):538-49. PubMed ID: 11599597
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Detection of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays.
    Moore C; Ross W; Coulter C; Adams L; Rana S; Vincent M; Soares J
    J Anal Toxicol; 2006 Sep; 30(7):413-8. PubMed ID: 16959132
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 9 alpha, 10 alpha-epoxyhexahydrocannabinol formation from delta 9-tetrahydrocannabinol by liver microsomes of phenobarbital-treated mice and its pharmacological activities in mice.
    Narimatsu S; Yamamoto I; Watanabe K; Yoshimura H
    J Pharmacobiodyn; 1983 Aug; 6(8):558-64. PubMed ID: 6315913
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Studies on the beta-oxidative metabolism of delta 1- and delta 6-tetrahydrocannabinol in the mouse. The in vivo biotransformation of metabolites oxidized in the side chain.
    Harvey DJ; Leuschner JT
    Drug Metab Dispos; 1985; 13(2):215-9. PubMed ID: 2859171
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacological potency of R- and S-3'-hydroxy-delta 9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity.
    Martin BR; Kallman MJ; Kaempf GF; Harris LS; Dewey WL; Razdan RK
    Pharmacol Biochem Behav; 1984 Jul; 21(1):61-5. PubMed ID: 6087379
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vitro metabolic formation of a new metabolite, 6 beta-hydroxymethyl-delta 9-tetrahydrocannabinol from cannabidiol through an epoxide intermediate and its pharmacological effects on mice.
    Nagai K; Watanabe K; Narimatsu S; Gohda H; Matsunaga T; Yamamoto I; Yoshimura H
    Biol Pharm Bull; 1993 Oct; 16(10):1008-13. PubMed ID: 8287029
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Marijuana metabolites in urine of man. X. Identification of marijuana use by detection of delta 9-tetrahydrocannabinol-11-oic acid using thin-layer chromatography.
    Kanter SL; Hollister LE; Musumeci M
    J Chromatogr; 1982 Jan; 234(1):201-8. PubMed ID: 6276425
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rectal bioavailability of delta-9-tetrahydrocannabinol from the hemisuccinate ester in monkeys.
    ElSohly MA; Stanford DF; Harland EC; Hikal AH; Walker LA; Little TL; Rider JN; Jones AB
    J Pharm Sci; 1991 Oct; 80(10):942-5. PubMed ID: 1664466
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Plasma and brain levels of delta 6-THC and seven monooxygenated metabolites correlated to the cataleptic effect in the mouse.
    Ohlsson A; Widman M; Carlsson S; Ryman T; Strid C
    Acta Pharmacol Toxicol (Copenh); 1980 Oct; 47(4):308-17. PubMed ID: 6258385
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of six substituted 4''-hydroxy-metabolites of of delta1-tetrahydrocannabinol in mouse liver.
    Harvey DJ; Paton WD
    Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):435-46. PubMed ID: 705022
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Activation of brain prostanoid EP3 receptors via arachidonic acid cascade during behavioral suppression induced by Delta8-tetrahydrocannabinol.
    Yamaguchi T; Kubota T; Watanabe S; Yamamoto T
    J Neurochem; 2004 Jan; 88(1):148-54. PubMed ID: 14675158
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A metabolic interaction in vivo between cannabidiol and 1 -tetrahydrocannabinol.
    Jones G; Pertwee RG
    Br J Pharmacol; 1972 Jun; 45(2):375-7. PubMed ID: 5048656
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oxidation mechanism of 7-hydroxy-delta 8-tetrahydrocannabinol and 8-hydroxy-delta 9-tetrahydrocannabinol to the corresponding ketones by CYP3A11.
    Matsunaga T; Tanaka H; Higuchi S; Shibayama K; Kishi N; Watanabe K; Yamamoto I
    Drug Metab Dispos; 2001 Nov; 29(11):1485-91. PubMed ID: 11602526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.